Device Trial Radar · NCT02448875
Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma
Last checked: Nov 20, 2026Latest source record: Jun 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
192
Actual
Start
Jun 21, 2013
Primary completion
Jun 22, 2017
Study completion Jun 22, 2017
Sponsor
- Lead sponsor
- Transcend Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 20, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and effectiveness of the use of visco-assisted CyPass® Micro-Stent implantation for the lowering of intraocular pressure (IOP) in subjects who have open angle glaucoma (OAG).
Conditions
- Open Angle Glaucoma
Interventions
CyPass Micro-StentDevice
Small tube with a through-lumen designed to redirect aqueous fluid from the front to the back of the eye in order to reduce intraocular pressure. Designed to be permanently implanted in the eye.
ViscoelasticDevice
Healon 5 ophthalmic viscoelastic used to increase the size of the aqueous drainage area created by the CyPass Micro-Stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With ≥ 20% Decrease From Baseline to 12 Months Postoperative in IOP Without Use of Ocular Hypotensive MedicationTime frame: Baseline (Day -1), Month 12 PostOperative
Locations
6 sites in 4 countries. Site status is shown where the registry gives one.
Transcend Medical Investigative Site
Lübeck, Germany
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.